Ani Pharmaceuticals reported $1000 in Ordinary Share Capital for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Aerie Pharmaceuticals AERI:US $ 0.05M 0M
Ani Pharmaceuticals ANIP:US $ 0M 0M
Aurora Cannabis Inc ACB:CN 6.42B 123K
Biodelivery Sciences International BDSI:US $ 0.1M 0M
Canopy Growth Corp WEED:CN C$ 7.47B 5.16M
Depomed DEPO:US $ 0M 0M
Eli Lilly And LLY:US $ 598.2M 0.1M
Emergent Biosolutions EBS:US $ 0.1M 0M
Endo International Ordinary Shares ENDP:US $ 0.07M 0M
Flexion Therapeutics FLXN:US $ 50K 0
Heron Therapeutics HRTX:US $ 1.02M 0M
Hikma Pharmaceutical HIK:LN 41M 0
Knight Therapeutics Inc GUD:CN C$ 652.68M 15.74M
Lannett LCI:US $ 0.04M 0M
Nektar Therapeutics NKTR:US $ 0.02M 0M
Novartis NVS:US $ 901M 12M
Omeros OMER:US $ 625K 1000
Perrigo Ordinary Shares PRGO:US $ 7064.8M 16.9M
Teva Pharmaceutical TEVA:IT 57M 0
Teva Pharmaceutical Industries TEVA:US $ 57M 0M